Your browser doesn't support javascript.
loading
Author Correction: Dynamic regulation of hypoxia-inducible factor-1α activity is essential for normal B cell development.
Burrows, Natalie; Bashford-Rogers, Rachael J M; Bhute, Vijesh J; Peñalver, Ana; Ferdinand, John R; Stewart, Benjamin J; Smith, Joscelin E G; Deobagkar-Lele, Mukta; Giudice, Girolamo; Connor, Thomas M; Inaba, Akimichi; Bergamaschi, Laura; Smith, Sam; Tran, Maxine G B; Petsalaki, Evangelia; Lyons, Paul A; Espeli, Marion; Huntly, Brian J P; Smith, Kenneth G C; Cornall, Richard J; Clatworthy, Menna R; Maxwell, Patrick H.
Afiliação
  • Burrows N; Cambridge Institute for Medical Research, The Keith Peters Building, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK. nb470@cam.ac.uk.
  • Bashford-Rogers RJM; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK. nb470@cam.ac.uk.
  • Bhute VJ; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
  • Peñalver A; Nuffield Department of Medicine, Wellcome Centre for Human Genetics, Oxford, UK.
  • Ferdinand JR; Cambridge Institute for Medical Research, The Keith Peters Building, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
  • Stewart BJ; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
  • Smith JEG; Cambridge Institute for Medical Research, The Keith Peters Building, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
  • Deobagkar-Lele M; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
  • Giudice G; Molecular Immunity Unit, Department of Medicine, University of Cambridge, MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Connor TM; Molecular Immunity Unit, Department of Medicine, University of Cambridge, MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Inaba A; Cellular Genetics, Wellcome Sanger Institute, Hinxton, UK.
  • Bergamaschi L; Cambridge Institute for Medical Research, The Keith Peters Building, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
  • Smith S; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
  • Tran MGB; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Petsalaki E; European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, UK.
  • Lyons PA; Oxford Kidney Unit, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Espeli M; Molecular Immunity Unit, Department of Medicine, University of Cambridge, MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Huntly BJP; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
  • Smith KGC; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.
  • Cornall RJ; Cambridge Institute for Medical Research, The Keith Peters Building, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
  • Clatworthy MR; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
  • Maxwell PH; UCL Division of Surgery and Interventional Science, Royal Free Hospital, London, UK.
Nat Immunol ; 22(11): 1465, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34522040
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article